Cargando…
Cereblon contributes to the development of pulmonary fibrosis via inactivation of adenosine monophosphate-activated protein kinase α1
Pulmonary fibrosis is a progressive and lethal lung disease characterized by the proliferation and differentiation of lung fibroblasts and the accumulation of extracellular matrices. Since pulmonary fibrosis was reported to be associated with adenosine monophosphate-activated protein kinase (AMPK) a...
Autores principales: | Kang, Hyo Jae, Lee, Kyung Jin, Woo, Jisu, Kim, Jiyeon, Kim, Yun Kyu, Lee, Chang-Hoon, Yoo, Chul-Gyu, Lee, Kyoung-Hee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178361/ https://www.ncbi.nlm.nih.gov/pubmed/34002012 http://dx.doi.org/10.1038/s12276-021-00619-6 |
Ejemplares similares
-
Cereblon Deficiency Contributes to the Development of Elastase-Induced Emphysema by Enhancing NF-κB Activation
por: Heo, Eun-Young, et al.
Publicado: (2022) -
Cereblon Deletion Ameliorates Lipopolysaccharide-induced Proinflammatory Cytokines through 5′-Adenosine Monophosphate-Activated Protein Kinase/Heme Oxygenase-1 Activation in ARPE-19 Cells
por: Kim, Yun Kyu, et al.
Publicado: (2020) -
Enhanced Production of Adenosine Triphosphate by Pharmacological Activation of Adenosine Monophosphate-Activated Protein Kinase Ameliorates Acetaminophen-Induced Liver Injury
por: Hwang, Jung Hwan, et al.
Publicado: (2015) -
Adenosine monophosphate–activated protein kinase in diabetic nephropathy
por: Kim, Yaeni, et al.
Publicado: (2016) -
Adenosine monophosphate kinase activator α‐lipoic acid: A promising therapeutic agent for metabolic syndrome?
por: Lee, In‐Kyu
Publicado: (2011)